GRM5 and type 1 diabetes mellitus: Variants in the metabotropic glutamate receptor group I pathway, including GRM1 and GRM5, were enriched in the pathway analysis of a recent albuminuria GWAS among people with type 1 diabetes from the FinnDiane study [12] (no individuals overlapped with the current gene-aggregate meta-analysis).